Skip to content

menu

Rothwell, Figg, Ernst & Manbeck, P.C. logo
HomeAboutContact
RF EMerge logo

A Resource for Innovators

Topics

GuidanceTrends & AnalysisLegal DevelopmentsSubscribe
DNA Sequencing Data Processing Genetic Genomic Analysis

Abbvie and Regenexbio Agree to Develop and Commercialize Eye Disease Gene Therapy

By Xiaoban Xin on September 14, 2021
Posted in Featured, Legal Developments

On September 13, 2021, Regenxbio, a Maryland biotech company, and AbbVie announced that they have entered an agreement to develop…
Continue Reading Abbvie and Regenexbio Agree to Develop and Commercialize Eye Disease Gene Therapy

Crispr - gene editing

Moderna’s Next Steps: Spikevax Today, Gene Editing Tomorrow

By Vivian Tian on August 16, 2021
Posted in Featured, Trends & Analysis

Following the successful development (and financial success) of its mRNA vaccine, biotech company Moderna is now looking to expand into…
Continue Reading Moderna’s Next Steps: Spikevax Today, Gene Editing Tomorrow

Caribou Biosciences Raises $304M in Potentially the Largest Gene Editing IPO

By Anjali Jenna (AJ) Teigen on August 9, 2021
Posted in Featured, Trends & Analysis

Caribou Biosciences, Inc., a Berkeley, California-based CRISPR genome-editing biopharmaceutical company, raised $304M in an initial public offering, one of the…
Continue Reading Caribou Biosciences Raises $304M in Potentially the Largest Gene Editing IPO

Male Medical Researcher

American Gene Technologies Celebrates Milestone in HIV Cure Development

By Xiaoban Xin on July 30, 2021
Posted in Featured, Legal Developments

On July 15, 2021, American Gene Technologies (AGT), a Maryland biotech company, announced that the safety data in its Phase…
Continue Reading American Gene Technologies Celebrates Milestone in HIV Cure Development

Vaccine For Cancer

Amgen Acquires Multispecific Immunotherapy Biotech Startup TeneoBio

By Aydin H. Harston on July 28, 2021
Posted in Trends & Analysis

On July 27, 2021, Amgen announced that it will acquire Bay area-based Teneobio, a privately held, clinical stage biotechnology…
Continue Reading Amgen Acquires Multispecific Immunotherapy Biotech Startup TeneoBio

Next Up for BioNTech: Malaria

By Dan Shores on July 27, 2021
Posted in Featured, Trends & Analysis

mRNA pioneer BioNTech announced recently that it is developing an mRNA-based vaccine to attempt to eradicate malaria.  Its efforts are…

Continue Reading Next Up for BioNTech: Malaria

CRISPR CAS9 Gene editing tool. Genome edits, human dna genetic engineering and DNA code vector illustration

Prime Medicine Emerges with $315 Million to Develop Next Generation Gene Editing Platform

By Xiaoban Xin on July 26, 2021
Posted in Featured, Trends & Analysis

On July 13, 2021, Prime Medicine, a Massachusetts biotech company developing next generation gene editing technology, emerged from stealth mode…
Continue Reading Prime Medicine Emerges with $315 Million to Develop Next Generation Gene Editing Platform

http domain concept background, flat style

Domain Name “Trolls”: The Trademark Trial and Appeal Board May Have Offered A Way Out

By Davide F. Schiavetti on July 14, 2021
Posted in Featured, Trends & Analysis

In today’s world, e-commerce and online visibility are sine qua non for success. Businesses are willing to invest considerable sums…
Continue Reading Domain Name “Trolls”: The Trademark Trial and Appeal Board May Have Offered A Way Out

Location Pin Nevigation Icons on World Map Polygon Graphic Background with Connected Lines

A Framework for Protecting Your Invention Outside the U.S.

By Xiaoban Xin on June 22, 2021
Posted in Featured, Guidance

Patent protection outside the U.S. can be important for a company to enter the global market and to build relationships…
Continue Reading A Framework for Protecting Your Invention Outside the U.S.

Pitfalls of Attorney-Client Privilege and Tips for Corporate Officers and Employees

By Aydin H. Harston on June 16, 2021
Posted in Featured, Guidance

Elizabeth Holmes, former CEO of the now-defunct blood-testing technology company Theranos, recently learned a harsh lesson on the complexities and…
Continue Reading Pitfalls of Attorney-Client Privilege and Tips for Corporate Officers and Employees

Post navigation

 Newer PostsOlder Posts 
Rothwell, Figg, Ernst & Manbeck, P.C.
Subscribe to this Blog
New York
80 South Highland Ave
Ossining, NY 10562
914.941.5668
info@rfem.com
Washington, DC
607 14th St. NW
Suite 800
Washington, DC 20005
202.783.6040
info@rfem.com
Boston
10 Post Office Square
Suite 800
Boston, MA 02109
617.312.3101
info@rfem.com
RSS LinkedIn Twitter Facebook
Privacy PolicyDisclaimer

About Our Firm

To learn more about our firm and other practice areas, visit: www.rfem.com.

Rothwell Figg Blogs

  • Biosimilars Law Bulletin
  • Healthcare Marketing Law
  • Privacy Zone
  • PTAB Law Blog
  • Trademark Opposition Lawyer
Copyright © 2022, Rothwell, Figg, Ernst & Manbeck, P.C. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo

We use cookies to enhance your user experience. By continuing to use this site you are giving your consent for us to use cookies. For more information, please see our Privacy Policy.

Agree